Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Technical Analysis

Compare
349 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is 0.93, suggesting Immunome is a Sell.
Immunome’s (IMNM) 20-Day exponential moving average is 16.35, while Immunome’s (IMNM) share price is $17.86, making it a Buy.
Immunome’s (IMNM) 50-Day exponential moving average is 14.52, while Immunome’s (IMNM) share price is $17.86, making it a Buy.

Immunome (IMNM) Pivot Points

Nov 19, 2025, 06:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.95
16.65
17.39
18.09
18.83
19.53
20.26
Fibonacci
16.65
17.20
17.54
18.09
18.64
18.98
19.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Nov 19, 2025, 06:13 PM
Period
Simple
Exponential
MA5
17.41Buy
17.46Buy
MA10
16.71Buy
17.01Buy
MA20
16.40Buy
16.35Buy
MA50
13.89Buy
14.52Buy
MA100
11.89Buy
12.80Buy
MA200
10.24Buy
11.43Buy
Immunome’s (IMNM) 10-Day exponential moving average is 17.01, while Immunome’s (IMNM) share price is $17.86, making it a Buy.
Immunome’s (IMNM) 100-Day exponential moving average is 12.80, while Immunome’s (IMNM) share price is $17.86, making it a Buy.
Immunome’s (IMNM) stock price is $17.86 and Immunome’s (IMNM) 50-day simple moving average is 13.89, creating a Buy signal.
Immunome’s (IMNM) stock price is $17.86 and Immunome’s (IMNM) 100-day simple moving average is 11.89, creating a Buy signal.
Immunome’s (IMNM) stock price is $17.86 and Immunome’s (IMNM) 200-day simple moving average is 10.24, creating a Buy signal.

Immunome (IMNM) Technical Indicators

Nov 19, 2025, 06:13 PM
Name
Value
Implied Action
RSI (14)
62.61
Neutral
STOCH (9,6)
75.78
Neutral
STOCHRSI (14)
75.78
Neutral
MACD (12,26)
0.93
Sell
ADX (14)
40.10
Neutral
Williams %R
-22.35
Buy
CCI (14)
141.36
Sell
ATR (14)
1.23
-
Ultimate Oscillator
54.65
Neutral
ROC
13.32
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 62.61, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 40.10, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is 141.36, creating a Sell signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 13.32, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Strong Buy.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 62.61, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is 0.93, which suggests IMNM is a Sell.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 17.41, which suggests IMNM is a Buy.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 16.40, which suggests IMNM is a Buy.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 13.89, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 10.24, which suggests IMNM is a Buy.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -22.35, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is 141.36, which suggests IMNM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis